Le Lézard
Classified in: Health, Science and technology
Subject: Stock Sale/Buyback

KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)


KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), today announced that the compensation committee of KalVista's board of directors granted eight newly-hired employees inducement options to purchase an aggregate of 77,000 shares of KalVista common stock on November 1, 2023 as inducements material to each employee entering into employment with KalVista. The options were granted in accordance with Nasdaq Listing Rule 5635(c)(4).

The options have an exercise price of $8.77 per share, which was equal to the closing price of KalVista common stock on the grant date. One-fourth of the options vest on the one-year anniversary of the vesting commencement date and the remainder vest in equal monthly installments over the next three years, in each case subject to the new employee's continued service with the company. Each stock option has a 10-year term and is subject to the terms and conditions of KalVista's Inducement Equity Incentive Plan and a stock option agreement covering the grant.

About KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors for diseases with significant unmet need. KalVista is developing sebetralstat as an oral on-demand therapy for HAE attacks and has achieved target enrollment for the phase 3 KONFIDENT clinical trial. In addition, KalVista's oral Factor XIIa inhibitor program represents a new generation of therapies that may further improve the treatment for people living with HAE and other diseases.

For more information about KalVista, please visit www.kalvista.com

For more information on the sebetralstat HAE on-demand Phase 3 KONFIDENT study, please visit www.konfidentstudy.com


These press releases may also interest you

at 03:35
Global technology corporation FPT and Australian strategic consultancy firm, Ascending Strategies, recently inked a partnership agreement. The collaboration is set to foster innovation and business development across the Australasia region. Under...

at 03:07
Global consulting firm J.S. Held, proudly celebrating 50 transformative years, announces Lee Spirer as its new President and Chief Operating Officer (COO), reporting to Chief Executive Officer (CEO), Jonathon Held.  Lee Spirer is a transformational...

at 03:01
SolarBank Corporation (Cboe CA: SUNN) ("SolarBank" or the "Company") is pleased to announce its plans to develop a 2.9 MW DC ground-mount solar power project known as the Silver Springs project (the "Project") on a site located in Gainesville, New...

at 03:00
MD Logistics LLC (hereinafter "MD"), a group company of NIPPON EXPRESS HOLDINGS, INC., is remaking the North Area of its existing warehouse in Plainfield in the U.S. state of Indiana into a dedicated pharmaceutical facility that will commence...

at 03:00
Compliancy Group strives to educate on all things healthcare compliance. Understanding how breaches occur and how to prevent them is a key component of compliance. Each month, Compliancy Group releases a breach report to spread awareness. Hacking...

at 03:00
In an op-ed published in The Hill on Sept. 28, 2024,...



News published on and distributed by: